Epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) have been validated to define the tumor microenvironment (TME) in breast cancers at a single-cell level [35]. Here, ESR1 is linked to breast carcinoma.